ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 2604 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 2604; 2) Community: the network communities that were significantly associated with the response to NSC 2604; 3) Molecule: the relationships between components within communities and NSC 2604; 4) MDR: the compounds that were significantly associated with the NSC 2604.

NSC Compound Enrichment Correlation
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.0388857481216103 0.60399108
NSC 286122 Null 0.0388857481216103 0.40469169
NSC 300288 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-[2-(dimethylamino)ethyl]-5-nitro- 0.0388857481216103 0.097779481
NSC 302289 BOHLMANN K2631 0.0388857481216103 0.53068795
NSC 328403 Acetamide, N-(4-formyl-5,6,7,9-tetrahydro-1,2,3,10- tetramethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0388857481216103 0.38852864
NSC 339578 Null 0.0388857481216103 0.17786738
NSC 404027 Null 0.0388857481216103 0.18644517
NSC 44580 9H-Purin-2-amine, 6-[[(2-chlorophenyl)methyl]thio]-9-propyl- 0.0388857481216103 0.25751952
NSC 617965 Null 0.0388857481216103 0.12904598
NSC 626167 Aplidazole C . TFA 0.0388857481216103 0.28202714
Total:74  Current:49    [First] [Prev] [Next] [Last]